Amryt Pharma is an England-based pharmaceutical company that develops and commercializes therapeutics for the treatment of debilitating diseases.Read more
Amryt Pharma's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 2.9B. Over the last four quarters, Amryt Pharma's revenue has grown by 13%. Specifically, in Q4 2021's revenue was $54.7M; in Q3 2021, it was $56.5M; in Q2 2021, it was $62.8M; in Q1 2021, Amryt Pharma's revenue was $48.4M.